Prostate-Specific Antigen
"Prostate-Specific Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer.
Descriptor ID |
D017430
|
MeSH Number(s) |
D08.811.277.656.300.760.442.750 D08.811.277.656.959.350.442.750 D12.776.866.249.500 D23.050.285.625 D23.101.140.625
|
Concept/Terms |
Prostate-Specific Antigen- Prostate-Specific Antigen
- gamma-Seminoprotein
- gamma Seminoprotein
- Prostate Specific Antigen
- hK3 Kallikrein
- Kallikrein, hK3
- Semenogelase
- Kallikrein hK3
- Seminin
|
Below are MeSH descriptors whose meaning is more general than "Prostate-Specific Antigen".
Below are MeSH descriptors whose meaning is more specific than "Prostate-Specific Antigen".
This graph shows the total number of publications written about "Prostate-Specific Antigen" by people in this website by year, and whether "Prostate-Specific Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2007 | 0 | 1 | 1 | 2019 | 1 | 1 | 2 | 2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Prostate-Specific Antigen" by people in Profiles.
-
Deniffel D, Abraham N, Namdar K, Dong X, Salinas E, Milot L, Khalvati F, Haider MA. Using decision curve analysis to benchmark performance of a magnetic resonance imaging-based deep learning model for prostate cancer risk assessment. Eur Radiol. 2020 Dec; 30(12):6867-6876.
-
Beheshti M, Manafi-Farid R, Geinitz H, Vali R, Loidl W, Mottaghy FM, Langsteger W. Multiphasic 68Ga-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients. J Nucl Med. 2020 10; 61(10):1484-1490.
-
Abrahamyan L, Huszti E, Bremner KE, Pechlivanoglou P, Mitsakakis N, Krahn M. New Insights into the Epidemiology of Prostate Cancer in Ontario. Cancer Invest. 2019; 37(10):513-523.
-
Deniffel D, Zhang Y, Salinas E, Satkunasivam R, Khalvati F, Haider MA. Reducing Unnecessary Prostate Multiparametric Magnetic Resonance Imaging by Using Clinical Parameters to Predict Negative and Indeterminate Findings. J Urol. 2020 02; 203(2):292-298.
-
Vitiello GA, Sayed BA, Wardenburg M, Perez SD, Keith CG, Canter DJ, Ogan K, Pearson TC, Turgeon N. Utility of Prostate Cancer Screening in Kidney Transplant Candidates. J Am Soc Nephrol. 2016 07; 27(7):2157-63.
-
Beheshti M, Vali R, Langsteger W. [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer. Eur J Nucl Med Mol Imaging. 2007 Aug; 34(8):1316-7; author reply 1318-9.
-
Farhat WA, Habbal AA, Khauli RB. A guideline to clinical utility of prostate specific antigen. Saudi Med J. 2000 Mar; 21(3):223-7.
-
Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. Genomics. 1999 Dec 01; 62(2):251-9.
-
Luo L, Herbrick JA, Scherer SW, Beatty B, Squire J, Diamandis EP. Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem Biophys Res Commun. 1998 Jun 29; 247(3):580-6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|